CH643737A5 - Preparation of a solid material composed of ergot peptide alkaloids and polyvinylpyrrolidone - Google Patents
Preparation of a solid material composed of ergot peptide alkaloids and polyvinylpyrrolidone Download PDFInfo
- Publication number
- CH643737A5 CH643737A5 CH1244876A CH1244876A CH643737A5 CH 643737 A5 CH643737 A5 CH 643737A5 CH 1244876 A CH1244876 A CH 1244876A CH 1244876 A CH1244876 A CH 1244876A CH 643737 A5 CH643737 A5 CH 643737A5
- Authority
- CH
- Switzerland
- Prior art keywords
- polyvinylpyrrolidone
- preparation
- methanesulfonate
- peptide alkaloids
- solid material
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH643737A5 true CH643737A5 (en) | 1984-06-29 |
Family
ID=5959411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1244876A CH643737A5 (en) | 1975-10-17 | 1976-10-01 | Preparation of a solid material composed of ergot peptide alkaloids and polyvinylpyrrolidone |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5854122B2 (es) |
| AT (1) | AT362510B (es) |
| AU (1) | AU508628B2 (es) |
| BE (1) | BE847368A (es) |
| CA (1) | CA1079641A (es) |
| CH (1) | CH643737A5 (es) |
| CS (1) | CS199647B2 (es) |
| DE (1) | DE2546577B2 (es) |
| DK (1) | DK146194C (es) |
| ES (1) | ES452420A1 (es) |
| FI (1) | FI762875A (es) |
| FR (1) | FR2327764A1 (es) |
| GB (1) | GB1560406A (es) |
| GR (1) | GR61268B (es) |
| HK (1) | HK3183A (es) |
| HU (1) | HU172533B (es) |
| IE (1) | IE43778B1 (es) |
| IL (1) | IL50686A (es) |
| MY (1) | MY8400063A (es) |
| NL (1) | NL184558C (es) |
| NO (1) | NO144468C (es) |
| NZ (1) | NZ182341A (es) |
| PH (1) | PH14513A (es) |
| PT (1) | PT65719B (es) |
| SE (1) | SE430379B (es) |
| SG (1) | SG63082G (es) |
| SU (1) | SU1165223A3 (es) |
| ZA (1) | ZA766166B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
| US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
| WO1980001242A1 (en) * | 1978-12-21 | 1980-06-26 | Sandoz Ag | Galenical preparation |
| FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| NL194389C (nl) * | 1984-06-14 | 2002-03-04 | Novartis Ag | Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager. |
| EP0277092B1 (de) * | 1987-01-14 | 1992-01-29 | Ciba-Geigy Ag | Therapeutisches System für schwerlösliche Wirkstoffe |
| FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
| DE4401646A1 (de) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimal freisetzende Kava-Extrakte |
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| CO4970793A1 (es) * | 1997-12-22 | 2000-11-07 | Schering Corp | Composicion para dispersion molecular con biodisponibilidad aumentada |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| JP4965784B2 (ja) * | 1999-12-03 | 2012-07-04 | ポリケム・ソシエテ・アノニム | バイオアベイラビリティの向上した麦角アルカロイドの徐放性医薬組成物の製造法及びその組成物 |
| US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
| PT1638527E (pt) * | 2003-06-27 | 2007-02-28 | Bioprogress Spa | Produto compósito obtido por co-trituração de um princípio activo com um copolímero de n-vinil-2-pirrolidona/acetato de vinilo |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-08 FI FI762875A patent/FI762875A/fi not_active Application Discontinuation
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/xx not_active IP Right Cessation
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH643737A5 (en) | Preparation of a solid material composed of ergot peptide alkaloids and polyvinylpyrrolidone | |
| AT398165B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung | |
| EP0317878B1 (de) | Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen | |
| EP0181515B1 (de) | Verfahren zur Herstellung einer wässrigen Überzugsmitteldispersion und ihre Verwendung zum Überziehen von Arzneimitteln | |
| DE19681389B3 (de) | Dosierungsform, umfassend Oxybutynin | |
| DE3420283A1 (de) | Nifedipin-trockenpraeparate und verfahren zu ihrer herstellung | |
| LU81503A1 (de) | Arzneimittel-retardform mit unloeslichen poroesen diffusioshuellen | |
| CH672736A5 (es) | ||
| EP2150238A1 (de) | Herstellungsverfahren für adsorbate eines rasagilinsalzes mit einem wasserlöslichen hilfsstoff | |
| DE2741755A1 (de) | Ueberzugsmassen auf polymerbasis fuer biologisch aktive praeparate und verfahren zur herstellung der ersteren sowie biologisch aktive praeparate und verfahren zur herstellung der letzteren | |
| DE2336807C2 (de) | Darmlösliche pharmazeutische Kapseln | |
| EP0184754A2 (de) | Pankreasenzympräparate und Verfahren zu deren Herstellung | |
| DE69737373T2 (de) | Östroprogestatives Antikonzeptionsmittel | |
| DE10139115A1 (de) | Citalopram enthaltende pharmazeutische Zusammensetzung | |
| DE2732335C2 (de) | Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten | |
| DE2719690A1 (de) | Stabilisierte prostaglandinzubereitung und verfahren zur herstellung derselben | |
| DE3839825C2 (es) | ||
| DE2950154C2 (es) | ||
| DE2146174A1 (de) | Direkt gepresste Tablette und Verfahren zu ihrer Herstellung | |
| DE2546371A1 (de) | Neue galenische formen | |
| DE2621906C2 (es) | ||
| DE2802114A1 (de) | Neue pharmazeutische zusammensetzung und verfahren zu deren herstellung | |
| DE3013059A1 (de) | Neue galenische zusammensetzung | |
| DE60311796T2 (de) | Methode zur verbesserung der oberflächeneigenschaften von tabletten | |
| DE2809618A1 (de) | Neues therapeutisches praeparat und verfahren zu dessen herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |